PGNX - Progenics Pharmaceuticals - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

with an average price target of $5.21. This is a potential upside of $5.21 (0%) from yesterday's end of day stock price of $0.

Progenics Pharmaceuticals's activity chart (see below) currently has 16 price targets and 14 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 50% with an average time for these price targets to be met of 155.25 days.

Most recent stock forecast was given by CHAD MESSER from NEEDHAM on 14-Mar-2019. First documented stock forecast 12-Mar-2008.

Best performing analysts who are covering PGNX - Progenics Pharmaceuticals:

Jason Wittes Chad Messer Gena Wang Jonathan Aschoff

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

10

$5.9 (143.90%)

12

5 years 15 days ago

3/9 (33.33%)

$5.58 (126.24%)

321

Buy

11

$6.9 (168.29%)

9

7 years 2 months 18 days ago

3/3 (100%)

$2.1 (23.60%)

165

Buy

11

$6.9 (168.29%)

11

7 years 5 months 2 days ago

2/3 (66.67%)

$5.29 (81.82%)

135

Buy

14

$9.9 (241.46%)

14

7 years 8 months 9 days ago

0/2 (0%)

$7.86 (128.01%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is PGNX (Progenics Pharmaceuticals) average time for price targets to be met?

On average it took 155.25 days on average for the stock forecasts to be realized with a an average price target met ratio 50

Which analyst has the current highest performing score on PGNX (Progenics Pharmaceuticals) with a proven track record?

JASON WITTES

Which analyst has the current lower performing score on PGNX (Progenics Pharmaceuticals) with a proven track record?

JONATHAN ASCHOFF

Which analyst has the most public recommendations on PGNX (Progenics Pharmaceuticals)?

Jason Wittes has 10 price targets and 7 ratings on PGNX

Which analyst is the currently most bullish on PGNX (Progenics Pharmaceuticals)?

Jonathan Aschoff with highest potential upside - $9.9

Which analyst is the currently most reserved on PGNX (Progenics Pharmaceuticals)?

Chad Messer with lowest potential downside - $5.9

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?